![Medicine / Cardiology / Lipoproteins / Lysosomal Acid Lipase Deficiency / Clinical research / Cholesteryl ester storage disease / Wolman disease / Niacin / Clinical trial / Health / Rare diseases / Lipid storage disorders Medicine / Cardiology / Lipoproteins / Lysosomal Acid Lipase Deficiency / Clinical research / Cholesteryl ester storage disease / Wolman disease / Niacin / Clinical trial / Health / Rare diseases / Lipid storage disorders](https://www.pdfsearch.io/img/b52e7c5e5494f1b42754c65dc1206914.jpg)
| Document Date: 2014-10-09 07:26:12 Open Document File Size: 312,69 KBShare Result on Facebook
City LEXINGTON / / Company Synageva BioPharma Corp. / / / Event Conference Call / FDA Phase / / IndustryTerm biopharmaceutical company developing therapeutic products / imaging / / MedicalCondition abdominal pain / rare diseases / disease / atherosclerosis / headache / nasopharyngitis / nausea / Dyslipidemia / lysosomal acid lipase deficiency / cirrhosis / Cholesteryl Ester Storage Disease / Wolman disease / diseases / lysosomal storage disease / liver injury / constipation / LAL Deficiency / Fibrosis / / MedicalTreatment enzyme replacement therapy / / Organization FDA / Ministry of Health / / Person Anthony Quinn / Sanj K. Patel / Matthew Osborne / / / Position President and Chief Executive Officer / Executive Vice President and Chief / forward / Officer / / Product SEBELIPASE ALFA IN / / ProvinceOrState Massachusetts / / Technology magnetic resonance imaging / MRI / / URL www.synageva.com / /
SocialTag |